Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer.

Joanne L Blum Nicholas Robert Jay Andersen Anne Favret Patrick Ward Cynthia Osborne John Pippen

J Clin Oncol

Joanne L. Blum, Texas Oncology, Baylor Sammons Cancer Center, US Oncology, Dallas, TX; Nicholas Robert, McKesson Specialty Health/US Oncology Network, The Woodlands, TX; Jay Andersen, Compass Oncology, US Oncology, Portland, OR; Anne Favret, Virginia Cancer Specialist, US Oncology, Fairfax, VA; Patrick Ward, US Oncology, Cincinnati, OH; and Cynthia Osborne and John Pippen, Texas Oncology, Baylor Sammons Cancer Center, US Oncology, Dallas, TX.

Published: February 2018

Download full-text PDF	Source
http://dx.doi.org/10.1200/JCO.2017.75.3756	DOI Listing

Publication Analysis

Top Keywords

biomarkers guide

guide decisions

decisions adjuvant

adjuvant systemic

systemic therapy

therapy early-stage

early-stage invasive

invasive breast

breast cancer

biomarkers

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!